Arthritis Drug Halts Progression of Alzheimer's

Thursday, 17 Jul 2014 10:58 AM

By Sylvia Booth Hubbard

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink
 
 
An anti-inflammatory drug used to treat rheumatoid arthritis may stop the progression of Alzheimer's, according to a randomized controlled study from the United Kingdom's University of Southampton.
 
Researchers tested the drug Etanercept, normally used to treat autoimmune diseases, such as rheumatoid arthritis and plaque psoriasis, on patients with mild to moderate Alzheimer's. Patients were given either a weekly injection of Etanercept or a placebo. At the end of six months, they were tested for memory function, behavior, and how they functioned in daily activities.

ALERT: These 7 Things Activate Alzheimer’s In Your Brain
 
The mental and physical function of patients who took Etanercept did not worsen during the six-month follow up while the abilities of those on placebo declined.
 
"Our results are better than we expected," said study leader professor Clive Holmes. "We have shown that using Etanercept in patients who have Alzheimer’s disease would be safe and has positive outcomes after six months."

Etanercept works by reducing levels of a protein in the blood called TNFa which is released by blood cells as part of the body's inflammatory response. Previous studies have shown that levels of TNFa are high in people with Alzheimer's.

"A large number of anti-inflammatory approaches have been tried in patients with established Alzheimer's, but with little evidence of efficacy," Holmes said. "There are very few studies that have come out with everything moving in the right direction.

"We have shown that a targeted approach against TNFa offers protection against the development of the disease," he said. "Our study was small and lasted for six months so it needs to be developed further, however our projections suggest that the benefits would continue."
 
Editor’s Note: These 6 Things Make Your Arthritis and Joint Pain Worse


© 2014 NewsmaxHealth. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Comments
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Retype Email:
Country
Zip Code:
Privacy: We never share your email.
 
Find Your Condition
You May Also Like
Around the Web
Most Commented

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

NEWSMAXHEALTH.COM
© Newsmax Media, Inc.
All Rights Reserved